2024/08/28 17:19:59 | |
---|---|
Price | |
10,856.00 HUF | |
Difference | -0.88% (-96.00) |
ISIN | DE000BAY0017 |
Symbol | BAYN |
Exchange | Budapest Stock Exchange |
Currency | HUF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 27,375 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 10,000.00 HUF (15) |
Ask (Ask size) | 11,688.00 HUF (8) |
Open | 10,856.00 HUF |
High | 10,856.00 HUF |
Low | 10,856.00 HUF |
Close (prev. day) | 10,952.00 HUF |
VWAP | 10,856.00 HUF |
Volume (pcs) | 19 |
Trading volume | 206,264.00 |
Number of trades | 1 |
Last size | - |
Related Futures | 54 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/03 |
![]() |
Global Strategy 3Q 2024 |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/06/14 |
![]() |
Global Equity Ratings |
![]() |
2024/04/26 |
![]() |
Global Equity Ratings |
![]() |
2024/08/28 17:19:59 | |
---|---|
Price | |
10,856.00 HUF | |
Difference | -0.88% (-96.00) |
ISIN | DE000BAY0017 |
Symbol | BAYN |
Exchange | Budapest Stock Exchange |
Currency | HUF |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 27,375 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 10,000.00 HUF (15) |
Ask (Ask size) | 11,688.00 HUF (8) |
Open | 10,856.00 HUF |
High | 10,856.00 HUF |
Low | 10,856.00 HUF |
Close (prev. day) | 10,952.00 HUF |
VWAP | 10,856.00 HUF |
Volume (pcs) | 19 |
Trading volume | 206,264.00 |
Number of trades | 1 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -3.50% | -43.40% | -34.51% |
Perf (abs.) | -394.00 | -8,324.00 | -5,720.00 |
Beta | 1.10 | 1.16 | 0.80 |
Volatility | 46.18 | 42.44 | 37.66 |
Ø price 5 days | Ø volume 5 days (pcs.) | 10,930.00 HUF (29) |
Ø price 30 days | Ø volume 30 days (pcs.) | 10,668.89 HUF (101) |
Ø price 100 days | Ø volume 100 days (pcs.) | 10,738.80 HUF (80) |
Ø price 250 days | Ø volume 250 days (pcs.) | 12,541.17 HUF (123) |
YTD High | date | 13,510.00 HUF (2024/01/05) |
YTD Low | date | 9,980.00 HUF (2024/03/07) |
52 Weeks High | date | 19,696.00 HUF (2023/09/25) |
52 Weeks Low | date | 9,980.00 HUF (2024/03/07) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2024/08/30 | 21:52 | 27.89 EUR | 0.01 | 19 |
Bucharest Stock Exchange | 2024/08/28 | 14:50 | 136.62 RON | 0.00 | 1 |
Budapest Stock Exchange | 2024/08/28 | 17:19 | 10,856.00 HUF | 0.21 | 1 |
Duesseldorf | 2024/08/30 | 19:52 | 27.895 EUR | 0.00 | 6 |
Euronext Milan MTF Global Equity Market | 2024/08/30 | 17:44 | 28.32 EUR | 0.43 | 113 |
Euronext Milan MTF Trading After Hours | 2024/07/25 | 18:07 | 27.155 EUR | 0.00 | 1 |
FINRA other OTC Issues | 2024/08/30 | 17:16 | 30.8925 USD | 0.14 | 6 |
Frankfurt | 2024/08/30 | 21:12 | 27.915 EUR | 0.16 | 29 |
Hamburg | 2024/08/30 | 12:20 | 27.915 EUR | 0.00 | 2 |
Hanover | 2024/08/30 | 17:12 | 27.89 EUR | 0.00 | 4 |
London Stock Exchange European Trade Reporting | 2024/08/30 | 17:30 | 27.875 EUR | 0.00 | 4 |
Munich | 2024/08/30 | 12:12 | 27.925 EUR | 0.00 | 3 |
SIX Swiss Exchange | 2024/06/14 | 17:35 | 179.00 CHF | 0.00 | 1 |
SIX Swiss Exchange | 2023/02/21 | 17:35 | 60.00 EUR | 0.00 | 1 |
Stuttgart | 2024/08/30 | 21:59 | 27.845 EUR | 0.15 | 190 |
Tradegate | 2024/08/30 | 22:26 | 27.895 EUR | 3.50 | 587 |
Vienna Stock Exchange | 2024/08/30 | 17:32 | 27.915 EUR | 0.01 | 7 |
Xetra | 2024/08/30 | 17:37 | 27.865 EUR | 61.82 | 4,026 |
BAYER AG |
- - |
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen |
Telefon: +49-214-30-1 |
Fax: + |
E-mail: - |
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and womenšs health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany. |
B. Chuck Anderson | Chairman of Managing Board |
Heike Prinz | Member of Executive Committee |
Julio Triana | Member of Executive Committee |
Rodrigo Santos | Member of Executive Committee |
Stefan Oelrich | Member of Executive Committee |
Wolfgang Nickl | Member of Executive Committee |
Norbert Winkeljohann | Chairman of Supervisory Board |
Barbara Gansewendt | Member of Supervisory Board |
Ertharin Cousin | Member of Supervisory Board |
Nancy Simonian | Member of Supervisory Board |
Paul Achleitner | Member of Supervisory Board |
Alberto Weisser | Member of Supervisory Board |
Andrea Sacher | Member of Supervisory Board |
André van Broich | Member of Supervisory Board |
Claudia Schade | Member of Supervisory Board |
Colleen Goggins | Member of Supervisory Board |
Francesco Grioli | Member of Supervisory Board |
Frank Löllgen | Member of Supervisory Board |
Heike Hausfeld | Member of Supervisory Board |
Heinz Georg Webers | Member of Supervisory Board |
Horst Heinz Paul Baier | Member of Supervisory Board |
Jeffrey Ubben | Member of Supervisory Board |
Kimberly Marie Lein-Mathisen | Member of Supervisory Board |
Lori Schechter | Member of Supervisory Board |
Michael Westmeier | Member of Supervisory Board |
Yasmin Fahimi | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer